Holocene Advisors
LLY icon

Holocene Advisors’s Eli Lilly LLY Stock Holding History

Holocene Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-240,000
Closed -$35.5M – 801
2020
Q3 		$35.5M Buy
+240,000
New +$37.1M 0.27% 121

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Holocene Advisors's LLY Position: Q2 2026 in Review

Holocene Advisors reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2026, selling an estimated $11.1M and leaving 176,517 shares worth $212M. The position accounts for 0.48% of the portfolio, ranked #55.

Holocene Advisors first reported a position in LLY in Q4 2017 and has held it in 16 quarters since. The position peaked at $530M in Q2 2025. 4,639 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Holocene Advisors held 176,517 shares of Eli Lilly worth $212M as of Q2 2026.
  • Holocene Advisors sold 10,842 Eli Lilly shares in Q2 2026, an estimated $11.1M.
  • Eli Lilly made up 0.48% of Holocene Advisors's portfolio in Q2 2026, its #55 holding.
  • Holocene Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 16 quarters since.
  • Holocene Advisors's Eli Lilly position peaked at $530M in Q2 2025.
  • 4,639 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.